Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
J Card Surg ; 32(10): 604-612, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28929526

RESUMO

BACKGROUND: We analyzed our early and midterm results with aortic valve reimplantation surgery to determine the influence of Marfan syndrome and bicuspid valves on outcomes with this technique. METHODS: Between March 2004 and December 2015, 267 patients underwent aortic valve reimplantation operations. The mean diameter of the sinuses of Valsalva was 50 ± 3 mm and moderate/severe aortic regurgitation was present in 34.4% of these patients. A bicuspid aortic valve was present in 21% and 40% had Marfan syndrome. RESULTS: Overall 30-day mortality was 0.37% (1/267). Mean follow-up was 59.7 ± 38.7 months. Overall survival at 1, 3, and 5 years was 98 ± 8%, 98 ± 1%, and 94 ± 2%, respectively. Freedom from reoperation and aortic regurgitation >II was 99 ± 5%, 98 ± 8%, 96.7 ± 8%, and 99 ± 6%, 98 ± 1%, 98 ± 1%, respectively at 1, 3, and 5 years follow-up, with no differences between Marfan and bicuspid aortic valve groups. (p = 0.94 and p = 0.96, respectively). No endocarditis or thromboembolic complications were documented, and 93.6% of the patients did not receive any anticoagulation therapy. CONCLUSIONS: The reimplantation technique for aortic root aneurysms is associated with excellent clinical and functional outcomes at short and mid-term follow-up.


Assuntos
Aneurisma Aórtico/etiologia , Aneurisma Aórtico/cirurgia , Valva Aórtica/anormalidades , Valva Aórtica/cirurgia , Doenças das Valvas Cardíacas/complicações , Implante de Prótese de Valva Cardíaca/métodos , Síndrome de Marfan/complicações , Tratamentos com Preservação do Órgão/métodos , Adulto , Assistência ao Convalescente , Idoso , Aneurisma Aórtico/mortalidade , Insuficiência da Valva Aórtica/etiologia , Doença da Válvula Aórtica Bicúspide , Feminino , Implante de Prótese de Valva Cardíaca/mortalidade , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Seio Aórtico/patologia , Fatores de Tempo , Resultado do Tratamento
2.
Rev. esp. cardiol. (Ed. impr.) ; 70(9): 727-735, sept. 2017. ilus, graf, tab
Artigo em Espanhol | IBECS | ID: ibc-166500

RESUMO

Introducción y objetivos: La mayoría de los dispositivos de asistencia ventricular (DAV) de larga duración utilizados actualmente son intracorpóreos y de flujo continuo. Sus principales inconvenientes son el coste elevado y la imposibilidad de ofrecer soporte biventricular. El objetivo de este estudio es describir los resultados de una estrategia de implante de un DAV paracorpóreo de flujo pulsátil como puente al trasplante (PAT) en pacientes adultos. Métodos: Análisis retrospectivo de las características, complicaciones y resultados de una serie unicéntrica de pacientes consecutivos tratados con el DAV EXCOR como PAT entre 2009 y 2015. Resultados: En este periodo se implantaron 25 DAV, 6 de ellos biventriculares. En 12 pacientes la indicación fue directamente PAT y en 13 puente a la decisión debido a la presencia de contraindicaciones potencialmente reversibles o posibilidad de recuperación. Veinte pacientes (80%) alcanzaron el objetivo del trasplante cardiaco tras una mediana de soporte de 112 días (rango 8-239). Las principales complicaciones fueron: infecciosas (52% de los pacientes), neurológicas (32%, la mitad de ellas mortales), hemorrágicas (28%) y fallo del DAV que obligó a cambiar algún componente de este (28%). Conclusiones: El 80% de los pacientes tratados con el DAV EXCOR como PAT alcanzaron el objetivo tras una mediana de soporte de casi 4 meses. Las complicaciones más frecuentes fueron las infecciosas y las más graves las neurológicas. El empleo de estos DAV de flujo pulsátil como PAT, en nuestro medio, es una estrategia factible que consigue resultados similares a los DAV de flujo continuo (AU)


Introduction and objectives: Most long-term ventricular assist devices (VADs) that are currently implanted are intracorporeal continuous-flow devices. Their main limitations include their high cost and inability to provide biventricular support. The aim of this study was to describe the results of using paracorporeal pulsatile-flow VADs as a bridge to transplant (BTT) in adult patients. Methods: Retrospective analysis of the characteristics, complications, and outcomes of a single-center case series of consecutive patients treated with the EXCOR VAD as BTT between 2009 and 2015. Results: During the study period, 25 VADs were implanted, 6 of them biventricular. Ventricular assist devices were indicated directly as a BTT in 12 patients and as a bridge to decision in 13 due to the presence of potentially reversible contraindications or chance of heart function recovery. Twenty patients (80%) were successfully bridged to heart transplant after a median of 112 days (range, 8-239). The main complications included infectious (52% of patients), neurological events (32%, half of them fatal), bleeding (28%), and VAD malfunction requiring component replacement (28%). Conclusions: Eighty percent of patients with the EXCOR VAD as BTT achieved the goal after an average of almost 4 months of support. The most frequent complications were infectious, and the most severe were neurological. In our enivonment, the use of these pulsatile-flow VAD as BTT is a feasible strategy that obtains similar outcomes to those of intracorporeal continuous-flow devices (AU)


Assuntos
Humanos , Adulto , Coração Auxiliar , Disfunção Ventricular/cirurgia , Transplante de Coração/métodos , Condicionamento Pré-Transplante/métodos , Fluxo Pulsátil/fisiologia , Estudos Retrospectivos , Anticoagulantes/administração & dosagem
3.
Rev Esp Cardiol (Engl Ed) ; 70(9): 727-735, 2017 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28366497

RESUMO

INTRODUCTION AND OBJECTIVES: Most long-term ventricular assist devices (VADs) that are currently implanted are intracorporeal continuous-flow devices. Their main limitations include their high cost and inability to provide biventricular support. The aim of this study was to describe the results of using paracorporeal pulsatile-flow VADs as a bridge to transplant (BTT) in adult patients. METHODS: Retrospective analysis of the characteristics, complications, and outcomes of a single-center case series of consecutive patients treated with the EXCOR VAD as BTT between 2009 and 2015. RESULTS: During the study period, 25 VADs were implanted, 6 of them biventricular. Ventricular assist devices were indicated directly as a BTT in 12 patients and as a bridge to decision in 13 due to the presence of potentially reversible contraindications or chance of heart function recovery. Twenty patients (80%) were successfully bridged to heart transplant after a median of 112 days (range, 8-239). The main complications included infectious (52% of patients), neurological events (32%, half of them fatal), bleeding (28%), and VAD malfunction requiring component replacement (28%). CONCLUSIONS: Eighty percent of patients with the EXCOR VAD as BTT achieved the goal after an average of almost 4 months of support. The most frequent complications were infectious, and the most severe were neurological. In our enivonment, the use of these pulsatile-flow VAD as BTT is a feasible strategy that obtains similar outcomes to those of intracorporeal continuous-flow devices.


Assuntos
Insuficiência Cardíaca/terapia , Transplante de Coração , Coração Auxiliar , Adulto , Feminino , Hemorragia/epidemiologia , Humanos , Infecções/epidemiologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Acidente Vascular Cerebral/epidemiologia , Trombose/epidemiologia , Fatores de Tempo , Resultado do Tratamento
4.
Eur J Cardiothorac Surg ; 50(6): 1149-1157, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27283156

RESUMO

OBJECTIVES: Endocarditis in patients with ascending aortic prosthetic graft (AAPG) is a life-threatening complication. The purpose of this study was to examine the clinical presentation and prognosis of patients with AAPG endocarditis included in a large prospective infectious endocarditis multicentre study. METHODS: From January 2008 to April 2015, 3200 consecutive patients with infectious endocarditis according to the modified Duke criteria, were prospectively included in the 'Spanish Collaboration on Endocarditis Registry (GAMES)' registry. Twenty-seven definite episodes of endocarditis (0.8%) occurred in patients with AAPG. RESULTS: During the study period, 27 cases of endocarditis were detected in patients with AAPG. The median age of patients was 61 years [interquartile range (IQR) 51-68 years] and 23 (85.2%) patients were male. The median time from AAPG surgery to the episode of AAPG infection was 24 months (IQR 6-108 months). The most frequently isolated micro-organisms were coagulase-negative staphylococci and S. aureus (11 patients, 40.7%). Four patients (14.8%) underwent medical treatment, whereas surgery was performed in 21 (77.7%). Two patients (7.4%) died before surgery could be performed. The median hospital stay prior to surgery was 7 days (IQR 4-21 days). Surgery consisted of replacing previous grafts with a composite aortic graft (10 cases) or aortic homograft (2 patients), and removal of a large vegetation attached to the valve of a composite tube (1 case). Nine patients had an infected aortic valve prosthesis without evidence of involvement of the AAPG. Isolated redo-aortic valve replacement was performed in 8 (88.9%) of these patients. Reinfection occurring during 1 year of follow-up was not detected in any patient. Two patients (7.4%) died while awaiting surgery and 6 did so after surgery (22.2%). A New York Heart Association (NYHA) Class IV was associated with mortality in patients undergoing surgery (P < 0.019). CONCLUSIONS: Most cases of endocarditis in patients with AAPG occur late after initial surgery. Mortality rate of patients with AAPG endocarditis who undergo surgery is acceptable. NYHA Class IV before surgery is associated with an increased postoperative mortality.


Assuntos
Aorta/cirurgia , Implante de Prótese Vascular/efeitos adversos , Endocardite Bacteriana/etiologia , Enxerto Vascular/efeitos adversos , Idoso , Prótese Vascular , Implante de Prótese Vascular/métodos , Endocardite Bacteriana/epidemiologia , Endocardite Bacteriana/microbiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sistema de Registros , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/etiologia , Enxerto Vascular/métodos
7.
Infection ; 42(2): 425-8, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24163221

RESUMO

A 59-year-old Caucasian male presented with progressive dyspnea, arthralgias and fever for three days. A diastolic regurgitation murmur was detected in the aortic area. A transesophageal echocardiograph showed several vegetations and severe aortic regurgitation. Blood cultures yielded Neisseria gonorrhoeae beta-lactamase negative. The patient had not noticed any urogenital discomfort or urethral discharge. The patient successfully underwent surgery for septal abscess debridement. The patient received ceftriaxone 2 g bid for eight weeks and the clinical follow-up was uneventful. The review of the literature revealed a total of the 38 additional cases reported between 1980 and the present. The majority of the patients were young, male and with native valve involvement. There has been a clear tendency for left-sided valve involvement (especially in the aortic valve). All valve cultures were reported negative despite, in most cases, the marked tissue destruction. Polymerase chain reaction was performed in two patients and positive results were shown in both. Cultures of exudates from other locations were negative in most cases. One striking fact is the high proportion of patients who underwent surgery (72 %). Information regarding antibiotic sensitivity was available in 28 cases, with penicillin resistance reported in six patients (21 %) and intermediate sensitivity in four patients (14 %). Resistance to ciprofloxacin was reported in two cases (7 %). A rapid increase and distribution of isolates resistant to third generation cephalosporins have been recently detected. The mortality is high, particularly taking into account that most were young patients who had not presented previous heart disease.


Assuntos
Antibacterianos/uso terapêutico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/cirurgia , Gonorreia/complicações , Neisseria gonorrhoeae/isolamento & purificação , Contagem de Colônia Microbiana , Farmacorresistência Bacteriana , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/mortalidade , Gonorreia/tratamento farmacológico , Gonorreia/mortalidade , Gonorreia/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/fisiologia , Reação em Cadeia da Polimerase , Resultado do Tratamento
8.
Rev. esp. cardiol. (Ed. impr.) ; 66(10): 797-802, oct. 2013.
Artigo em Espanhol | IBECS | ID: ibc-115595

RESUMO

Introducción y objetivos. Los receptores de trasplante cardiaco que sobreviven más de 20 años están aumentando. Poco se conoce de su seguimiento, sus comorbilidades y su mortalidad. Identificar predictores de larga supervivencia puede guiar la selección de candidatos para los donantes disponibles. Métodos. Se revisó la información sobre la clase funcional, las comorbilidades y la mortalidad de pacientes trasplantados antes de 1992. Para identificar los predictores de supervivencia > 20 años, se construyó un modelo de regresión logística utilizando las variables asociadas a supervivencia en el análisis univariable. Resultados. Se comparó a 39 supervivientes con seguimiento > 20 años (el 26% del total) con 90 pacientes que sobrevivieron entre 1 y 20 años. Las principales complicaciones fueron hipertensión, disfunción renal, infecciones y neoplasias. Tras 30 meses de seguimiento, 6 murieron, lo que implica una mortalidad del 6%/año (frente a un 2,5-3% en los años 1 a 19). Las principales causas de muerte fueron infección (50%), cáncer (33%) y vasculopatía del injerto (17%). Los supervivientes eran más jóvenes y delgados, y tenían cardiopatía no isquémica y menos isquemia en cirugía. La regresión logística identificó la edad del receptor < 45 años (odds ratio = 3,9; intervalo de confianza del 95%, 1,6-9,7; p = 0,002) y la miocardiopatía idiopática (odds ratio = 3; intervalo de confianza del 95%, 1,4-7,8; p = 0,012) como predictores independientes de supervivencia > 20 años. Conclusiones. En nuestra serie, más del 25% sobrevive más de 20 años con el mismo injerto y lleva vida independiente a pesar de las comorbilidades. La edad del receptor < 45 años y la miocardiopatía idiopática se asociaron a larga supervivencia. Estos datos pueden ayudar a la asignación de donantes (AU)


Introduction and objectives. The number of heart-transplant recipients exceeding 20 years of follow-up is steadily increasing. However, little is known about their functional status, comorbidities, and mortality. Identifying the predictors of prolonged survival could guide the selection of candidates for the low number of available donors. Methods. Functional status, morbidities, and mortality of heart-transplant patients between 1984 and 1992 were analyzed. To identify predictors of 20-year survival, a logistic regression model was constructed using the covariates associated with survival in the univariate analysis. Results. A total of 39 patients who survived 20 years (26% of patients transplanted before 1992) were compared to 90 recipients from the same period who died between 1 and 20 years post-transplantation. Major complications were hypertension, renal dysfunction, infections, and cancer. After a mean follow-up of 30 months, 6 survivors had died, yielding a mortality rate of 6% per year (vs 2.5%-3% in years 1-19). Causes of mortality were infection (50%), malignancy (33%), and allograft vasculopathy (17%). Long-term survivors were younger and leaner, and had nonischemic cardiomyopathy and lower ischemic time. Logistic regression identified recipient age <45 years (odds ratio=3.9; 95% confidence interval, 1.6-9.7; P=.002) and idiopathic cardiomyopathy (odds ratio=3; 95% confidence interval, 1.4-7.8; P=.012) as independent predictors for 20-year survival. Conclusions. One fourth of all heart-transplant patients in our series survived >20 years with the same graft, and most enjoy independent lives despite significant comorbidities. Recipient age <45 years and idiopathic cardiomyopathy were associated with survival beyond 2 decades. These data may help decide donor allocation (AU)


Assuntos
Adulto , Pessoa de Meia-Idade , Humanos , Transplante de Coração/métodos , Transplante de Coração , Qualidade de Vida , Sobrevivência de Enxerto/fisiologia , Cardiomiopatia Hipertrófica/complicações , Terapia de Imunossupressão/instrumentação , Terapia de Imunossupressão/métodos , Fatores de Risco , Transplante de Coração/reabilitação , Transplante de Coração/tendências , Comorbidade , Razão de Chances , Taxa de Sobrevida , Intervalos de Confiança , Índice de Massa Corporal , Análise Multivariada
10.
Rev Esp Cardiol (Engl Ed) ; 66(10): 797-802, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24773860

RESUMO

INTRODUCTION AND OBJECTIVES: The number of heart-transplant recipients exceeding 20 years of follow-up is steadily increasing. However, little is known about their functional status, comorbidities, and mortality. Identifying the predictors of prolonged survival could guide the selection of candidates for the low number of available donors. METHODS: Functional status, morbidities, and mortality of heart-transplant patients between 1984 and 1992 were analyzed. To identify predictors of 20-year survival, a logistic regression model was constructed using the covariates associated with survival in the univariate analysis. RESULTS: A total of 39 patients who survived 20 years (26% of patients transplanted before 1992) were compared to 90 recipients from the same period who died between 1 and 20 years post-transplantation. Major complications were hypertension, renal dysfunction, infections, and cancer. After a mean follow-up of 30 months, 6 survivors had died, yielding a mortality rate of 6% per year (vs 2.5%-3% in years 1-19). Causes of mortality were infection (50%), malignancy (33%), and allograft vasculopathy (17%). Long-term survivors were younger and leaner, and had nonischemic cardiomyopathy and lower ischemic time. Logistic regression identified recipient age <45 years (odds ratio=3.9; 95% confidence interval, 1.6-9.7; P=.002) and idiopathic cardiomyopathy (odds ratio=3; 95% confidence interval, 1.4-7.8; P=.012) as independent predictors for 20-year survival. CONCLUSIONS: One fourth of all heart-transplant patients in our series survived >20 years with the same graft, and most enjoy independent lives despite significant comorbidities. Recipient age <45 years and idiopathic cardiomyopathy were associated with survival beyond 2 decades. These data may help decide donor allocation.


Assuntos
Causas de Morte , Transplante de Coração/mortalidade , Transplante de Coração/métodos , Qualidade de Vida , Adulto , Fatores Etários , Análise de Variância , Bases de Dados Factuais , Feminino , Seguimentos , Rejeição de Enxerto , Sobrevivência de Enxerto , Transplante de Coração/psicologia , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/mortalidade , Complicações Pós-Operatórias/fisiopatologia , Estudos Retrospectivos , Fatores Sexuais , Espanha , Análise de Sobrevida , Sobreviventes/estatística & dados numéricos , Fatores de Tempo , Doadores de Tecidos , Adulto Jovem
13.
J Heart Lung Transplant ; 30(6): 644-51, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21470878

RESUMO

BACKGROUND: Primary graft failure (PGF) is the leading cause of early mortality after heart transplantation (HT). Our aim is to propose a working definition of PGF and to develop a predictive risk score. METHODS: PGF was defined by four criteria reflecting significant myocardial dysfunction, severe hemodynamic impairment, early onset after HT, and absence of secondary causes of graft dysfunction. We identified independent risk factors for PGF in a derivation series of 621 HTs and constructed a predictive model. After proving its internal consistency we tested the model in a prospective validation series. RESULTS: The incidence and lethality of PGF in our series were 9% and 80%, respectively. We identified 6 multivariate risk factors for PGF (Right atrial pressure ≥ 10 mm Hg, recipient Age ≥ 60 years, Diabetes mellitus, Inotrope dependence, donor Age ≥ 30 years, Length of ischemic time ≥ 240 minutes--i.e., RADIAL). Analysis of isolated right ventricular failure showed similar predictors. The RADIAL score was obtained by adding 1 point for each of these factors present in a given HT. PGF incidence increased significantly as the RADIAL score increased (p < 0.001 for trend). Rates of actual and predicted PGF incidence for RADIAL subgroups showed a good correlation (C-statistic = 0.74). In a prospective validation cohort, RADIAL score kept its predictive ability. CONCLUSIONS: PGF as defined by these criteria showed a high impact on early post-HT mortality in our series. The RADIAL score showed good ability to predict the development of PGF, and could be useful in the prevention and early treatment of this complication.


Assuntos
Rejeição de Enxerto/etiologia , Transplante de Coração/efeitos adversos , Adolescente , Adulto , Idoso , Criança , Feminino , Rejeição de Enxerto/epidemiologia , Rejeição de Enxerto/mortalidade , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Estudos Retrospectivos , Medição de Risco/métodos , Fatores de Risco , Terminologia como Assunto , Adulto Jovem
14.
Physiol Meas ; 31(12): 1553-65, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20980717

RESUMO

In recent times, significant effort has been made to understand the mechanical behaviour of the arterial wall and how it is affected by the different vascular pathologies. However, to be able to interpret the results correctly, it is essential that the influence of other factors, such as aging or anisotropy, be understood. Knowledge of mechanical behaviour of the aorta has been customarily constrained by lack of data on fresh aortic tissue, especially from healthy young individuals. In addition, information regarding the point of rupture is also very limited. In this study, the mechanical behaviour of the descending thoracic aorta of 28 organ donors with no apparent disease, whose ages vary from 17 to 60 years, is evaluated. Tensile tests up to rupture are carried out to evaluate the influence of age and wall anisotropy. Results reveal that the tensile strength and stretch at failure of healthy descending aortas show a significant reduction with age, falling abruptly beyond the age of 30. This fact places age as a key factor when mechanical properties of descending aorta are considered.


Assuntos
Aorta Torácica/fisiologia , Saúde , Adolescente , Adulto , Fenômenos Biomecânicos/fisiologia , Cotovelo/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Resistência à Tração/fisiologia , Adulto Jovem
15.
Rev Esp Cardiol ; 63(5): 598-601, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20450854

RESUMO

Intravascular ultrasound (IVUS) has been successfully used to guide the implantation of stents in the thoracic aorta. However, its accuracy in measuring the diameter of the aortic lumen has not been clearly established. Thirteen patients with thoracic aortic disease underwent IVUS, and lumen diameter measurements were compared with those obtained by CT or magnetic resonance imaging. A total of 31 comparable measurements were obtained. The correlation was good (r=0.98; P< .001), with IVUS tending to give a larger minimum diameter than CT (systematic error, 0.59+/-1.8 mm; P=.077). Given that the aorta is often not circular, the diameter obtained by IVUS was also compared to the mean diameter obtained by CT, and it was found that these two measurements were more closely related (P=.425), except in aortic segments with significant eccentricity (i.e., >10%). In conclusion, IVUS was a reliable tool for measuring the diameter of the aorta, particularly in concentric segments where stents are normally placed. Consequently, IVUS could supplement conventional imaging techniques.


Assuntos
Aorta Torácica/diagnóstico por imagem , Ultrassonografia de Intervenção/métodos , Adulto , Idoso , Aorta Torácica/cirurgia , Aneurisma da Aorta Torácica/diagnóstico por imagem , Aneurisma da Aorta Torácica/cirurgia , Procedimentos Cirúrgicos Cardíacos , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Adulto Jovem
16.
Rev. esp. cardiol. (Ed. impr.) ; 63(5): 598-601, mayo 2010. ilus
Artigo em Espanhol | IBECS | ID: ibc-79361

RESUMO

El ultrasonido intravascular (IVUS) se ha utilizado con éxito para guiar la implantación de endoprótesis en aorta torácica. Sin embargo, su precisión para medir la luz aórtica no está definitivamente establecida. Evaluamos con IVUS a 13 pacientes con enfermedad de la aorta torácica, comparando el diámetro luminal con las medidas de tomografía computarizada (TC) o resonancia magnética. Se obtuvieron 31 mediciones comparables. La correlación fue buena (r = 0,98; p < 0,001), con un ligero sesgo positivo del IVUS respecto al diámetro mínimo por TC (error sistemático, 0,59 ± 1,8 mm; p = 0,077). Dado que la aorta con frecuencia no es circular, se comparó también con el diámetro medio de la TC, obteniéndose mayor aproximación a las medidas de IVUS (p = 0,425), excepto en segmentos con excentricidad significativa (> 10%). En conclusión, el IVUS resulta fiable para la medición de diámetros aórticos, especialmente en segmentos concéntricos donde se fijan las endoprótesis, y puede complementar las técnicas de imagen convencionales (AU)


Intravascular ultrasound (IVUS) has been successfully used to guide the implantation of stents in the thoracic aorta. However, its accuracy in measuring the diameter of the aortic lumen has not been clearly established. Thirteen patients with thoracic aortic disease underwent IVUS, and lumen diameter measurements were compared with those obtained by CT or magnetic resonance imaging. A total of 31 comparable measurements were obtained. The correlation was good (r=0.98; P < .001), with IVUS tending to give a larger minimum diameter than CT (systematic error, 0.59±1.8 mm; P=.077). Given that the aorta is often not circular, the diameter obtained by IVUS was also compared to the mean diameter obtained by CT, and it was found that these two measurements were more closely related (P=.425), except in aortic segments with significant eccentricity (i.e., >10%). In conclusion, IVUS was a reliable tool for measuring the diameter of the aorta, particularly in concentric segments where stents are normally placed. Consequently, IVUS could supplement conventional imaging techniques (AU)


Assuntos
Humanos , Ultrassonografia de Intervenção/métodos , Aneurisma da Aorta Torácica/cirurgia , Angioplastia com Balão/métodos , Coartação Aórtica/cirurgia , Ruptura Aórtica/cirurgia
17.
Rev Esp Cardiol ; 60(3): 259-67, 2007 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-17394871

RESUMO

INTRODUCTION AND OBJECTIVES: The thermomechanical behavior of human arteries is still not well characterized despite its importance for understanding arterial physiology, and for evaluating and improving surgical procedures. The aim of this study was to provide, for the first time, experimental data illustrating how the mechanical responses of two types of human artery -the carotid artery and the aorta- are affected by changes in temperature. METHODS: The mechanical properties of the arteries were derived in vitro from internal pressure-external diameter curves measured at four different temperatures (i.e., 17, 27, 37 and 42 degree C). Coefficients of expansion and stiffness were obtained by thermomechanical analysis. The condition of the arterial wall was determined histologically. RESULTS: The aorta and the carotid artery became slightly more compliant as the temperature increased. In both vessels, the coefficient of expansion depended critically on internal pressure. At low pressures, the coefficient of expansion was negative (i.e., the vessel contracted when heated), whereas close to a specific threshold pressure, which is different for each type of artery, the coefficient became positive. CONCLUSIONS: The mechanical behavior of arteries is affected by the combination of internal pressure and temperature. Consequently, the effect of this combination should be taken into account in clinical situations involving a change in temperature. Moreover, the strength of the effect depends on the type of artery under study. As a result, more detailed experimental data focusing on vessels of clinical interest are required.


Assuntos
Aorta/fisiologia , Artérias Carótidas/fisiologia , Humanos , Técnicas In Vitro , Pressão , Estresse Mecânico , Temperatura
18.
Rev. esp. cardiol. (Ed. impr.) ; 60(3): 259-267, mar. 2007. ilus, graf
Artigo em Es | IBECS | ID: ibc-053675

RESUMO

Introducción y objetivos. La respuesta termomecánica de las arterias humanas es poco conocida a pesar de su importancia para la comprensión de la fisiología arterial, y para la evaluación y mejora de los procedimientos quirúrgicos. El objetivo de este trabajo es aportar por vez primera datos experimentales que muestren cómo se ve afectada la respuesta mecánica de dos tipos de arterias humanas ­aorta y carótida­ por los cambios de temperatura. Métodos. La respuesta mecánica de las arterias se ha obtenido in vitro a través de la medición de las curvas presión interior-diámetro exterior para 4 temperaturas (17, 27, 37 y 42 oC). Se ha realizado un análisis termomecánico para obtener los coeficientes de dilatación y la rigidez del material. El estado de la pared arterial se ha evaluado mediante análisis histológico. Resultados. Las arterias aorta y carótida aumentan ligeramente su flexibilidad con la temperatura. El coeficiente de dilatación de ambos vasos depende críticamente de la presión interior aplicada. A bajas presiones, el coeficiente de dilatación es negativo (el vaso se contrae cuando se calienta), mientras que por encima de cierta presión umbral ­distinta para cada tipo de arteria­ el coeficiente de dilatación se hace positivo. Conclusiones. El efecto combinado de la presión interior y la temperatura afecta al comportamiento de las arterias y, por ello, debe ser tenido en cuenta al abordar situaciones clínicas que impliquen cambios de temperatura. La intensidad de este efecto depende del tipo de arteria estudiada, lo que requiere la obtención de datos más detallados, centrados en los vasos de interés clínico


Introduction and objectives. The thermomechanical behavior of human arteries is still not well characterized despite its importance for understanding arterial physiology, and for evaluating and improving surgical procedures. The aim of this study was to provide, for the first time, experimental data illustrating how the mechanical responses of two types of human artery ­the carotid artery and the aorta­ are affected by changes in temperature. Methods. The mechanical properties of the arteries were derived in vitro from internal pressure­external diameter curves measured at four different temperatures (i.e., 17, 27, 37 and 42 oC). Coefficients of expansion and stiffness were obtained by thermomechanical analysis. The condition of the arterial wall was determined histologically. Results. The aorta and the carotid artery became slightly more compliant as the temperature increased. In both vessels, the coefficient of expansion depended critically on internal pressure. At low pressures, the coefficient of expansion was negative (i.e., the vessel contracted when heated), whereas close to a specific threshold pressure, which is different for each type of artery, the coefficient became positive. Conclusions. The mechanical behavior of arteries is affected by the combination of internal pressure and temperature. Consequently, the effect of this combination should be taken into account in clinical situations involving a change in temperature. Moreover, the strength of the effect depends on the type of artery under study. As a result, more detailed experimental data focusing on vessels of clinical interest are required


Assuntos
Masculino , Feminino , Adulto , Humanos , Aorta/fisiologia , Artérias Carótidas/fisiologia , Pressão Sanguínea/fisiologia , Sistemas Pressurizados , Cadáver , Temperatura Corporal/fisiologia
19.
An. cir. card. cir. vasc ; 11(2): 111-114, mar.-abr. 2005. ilus
Artigo em Es | IBECS | ID: ibc-037538

RESUMO

Los aneurismas coronarios de gran tamaño, no ateroscleróticos y localizados en el tronco común de la arteria coronaria izquierda son excepcionales. Presentamos el caso de un paciente de 25 años, que a raíz de un evento coronario agudo fue diagnosticado de un aneurisma gigante en el tronco común izquierdo y enfermedad de 2 vasos. Discutimos el diagnóstico diferencial y postulamos como etiología más probable las secuelas de una enfermedad de Kawasaki atípica. El paciente fue sometido con éxito a una revascularización arterial completa del ventrículo izquierdo asociada a ligadura de la circunfleja proximal


Giant, non atherosclerotic aneurysms of the left main coronary artery are exceptional. We report the case of a 25-year-old patient who was diagnosed of a giant aneurysm of the left main coronary artery associated with two-vessel disease after the onset of an acute coronary event. Differential diagnosis is discussed and delayed sequelae of an atypical Kawasaki disease is presented as the most likely etiology. The patient underwent successful complete arterial revascularization of the left ventricle, associated with proximal circumflex coronary artery occlusion


Assuntos
Masculino , Adulto , Humanos , Aneurisma Coronário/diagnóstico , Aneurisma Coronário/cirurgia , Aneurisma Coronário/etiologia , Doença das Coronárias/diagnóstico , Doença das Coronárias/cirurgia , Síndrome de Linfonodos Mucocutâneos/diagnóstico , Síndrome de Linfonodos Mucocutâneos/cirurgia , Revascularização Miocárdica/métodos , Cirurgia Torácica/métodos , Diagnóstico Diferencial , Revascularização Miocárdica/tendências , Revascularização Miocárdica , Veia Safena/lesões , Veia Safena/patologia , Cirurgia Torácica/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...